India Capital Growth (IGC) Share Price, News & Analysis

Company Overview

Fund Objective: To provide long term capital appreciation by investing predominantly in listed mid and small cap Indian companies. Investments may also be made in large cap Indian companies where the Fund Manager believes long-term capital appreciation will be achieved. The Company may hold liquid assets (including cash) pending deployment in suitable investments. It is the Company’s declared policy not to hedge the exposure to the Indian Rupee.

Key Stats

• Today's Range: 158.50 to 160
• 50-Day Range: 155 to 197
• 52-Week Range: 143 to 199
• Volume: 708,722 shs
• Average Volume: 398,720 shs
• Market Capitalization: £138.14 million
• P/E Ratio: 3.23
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IGC Stock Analysis - Frequently Asked Questions

How have IGC shares performed this year?

India Capital Growth's stock was trading at GBX 192.50 at the start of the year. Since then, IGC stock has decreased by 16.9% and is now trading at GBX 160.
View the best growth stocks for 2025 here.

How do I buy shares of India Capital Growth?

Shares of IGC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of India Capital Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that India Capital Growth investors own include Meta Platforms (META), Tilray (TLRY), JinkoSolar (JKS), Nikola (NKLA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:IGC
• CUSIP: N/A
• CIK: N/A
• Web: www.indiacapitalgrowth.com
• Phone: 44 20 7068 9870
• Fax: N/A
• Employees: 61
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 49.52
• Trailing P/E Ratio: 3.23
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £43.14 million
• Net Margins: 93.35%
• Pretax Margin: N/A
• Return on Equity: 25.12%
• Return on Assets: 15.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 23.31
• Quick Ratio: 6.26

Sales & Book Value

• Annual Sales: £46.21 million
• Price / Sales: 2.99
• Cash Flow: GBX 1.64 per share
• Price / Cash Flow: 97.31
• Book Value: GBX 198.57 per share
• Price / Book: 0.81

Miscellaneous

• Outstanding Shares: 86,339,198
• Free Float: N/A
• Market Cap: £138.14 million
• Optionable: Not Optionable
• Beta: 0.70